Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-κB signaling

Antioxidants and Redox Signaling

Volumn 12, Issue 6, 2010, Pages 693-702

  Afzal, Muhammad R ^a   Haider, Husnain Kh ^a   Idris, Niagara Muhammad ^a   Jiang, Shujia ^a   Ahmed, Rafeeq P H ^a   Ashraf, Muhammad ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; DIAZOXIDE; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH FACTOR; HYDROGEN PEROXIDE; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEMO BINDING DOMAIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WORTMANNIN; ANDROSTANE DERIVATIVE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HEART FUNCTION; HEART INFARCTION; IN VIVO STUDY; MESENCHYME CELL; MUSCLE DEVELOPMENT; NONHUMAN; OXIDATIVE STRESS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STEM CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; FISCHER 344 RAT; GENE SILENCING; HEART INFARCTION PREVENTION; MALE; MESENCHYMAL STROMA CELL; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

RATTUS;

ANDROSTADIENES; ANIMALS; CELL SURVIVAL; DIAZOXIDE; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FEMALE; GENE SILENCING; HYDROGEN PEROXIDE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; OXIDATIVE STRESS; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 77649256725     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2755     Document Type: Article

References (24)

1. Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, Nikolaev A, Burg J, Strand S, Kiesslich R, Huber S, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Galle PR, Blessing M, Rose-John S, and Neurath MF. TGF-b suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21: 491-501, 2004.
2. Hahn JY, Hahn JY, Cho HJ, Kang HJ, Kim TS, Kim MH, Chung JH, Bae JW, Oh BH, Park YB, and Kim HS. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cyto-protective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol 9: 933-943, 2008.
3. Haider HKh and Ashraf M. Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol 45: 554-566, 2008.
4. Hall G, Hasday JD, and Rogers TB. Regulating the regulator: NF-kappaB signaling in heart. J Mol Cell Cardiol 41: 580-591, 2008.
5. Hoffmann A, Levchenko A, Scott ML, and Baltimore D. The IkappaB-NF-kappaB signaling module: Temporal control and selective gene activation. Science 298: 1241-1245, 2002.
6. Karin M. Nuclear factor-kappa B in cancer development and progression. Nature 441: 431-436, 2006.
7. Karin M and Lin A. NF-kB at the crossroads of life and death. Nature Immunol 3: 221-227, 2002.
8. Kuhnel F, Zender L, Paul Y, Tietze MK, Trautwein C, Manns M, and Kubicka S. NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis. J Biol Chem 275: 6421-6427, 2000
9. Li Q, Guo Y, Tan W, Ou Q, Wu WJ, Sturza D, Dawn B, Hunt G, Cui C, and Bolli R. Cardioprotection afforded by in-ducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway. Circulation 14: 1577-1584, 2007.
10. Mirotsou M, Zhang Z, Deb A, Zhang L, Gnecchi M, Noiseux N, Mu H, Pachori A, and Dzau V. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci USA 5: 643-648, 2007.
11. Misra A, Haudek SB, Knuefermann P, Vallejo JG, Chen ZJ, Michael LH, Sivasubramanian N, Olson EN, Entman ML, and Mann DL. Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction. Circulation 108: 3075-3078, 2003.
12. Murry CE, Jennings RB, and Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 5: 1124-1136, 1986.
13. Niagara MI, Haider H, Jiang S, and Ashraf M. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 100: 545-555, 2007.
14. Ockaili R, Emani VR, Okubo S, Brown M, Krottapalli K, and Kukreja RC. Opening of mitochondrial KATP channel induces early and delayed cardioprotective effect: role of nitric oxide. Am J Physiol 277: 25-34, 1999.
15. Park JM, Greten FR, Wong A, Westrick RJ, Arthur JS, Otsu K, Hoffmann A, Montminy M, and Karin M. Signaling pathways and genes that inhibit pathogen-induced macro-phage apoptosis: CREB and NF-kB as key regulators. Immunity 23: 319-329, 2005.
16. Rothwarf DM and Karin M. The NF-kB activation pathway: A paradigm in information transfer from membrane to nucleus. Sci STKE 1999: RE1, 1999.
17. Toma C, Pittenger MF, Cahill KS, Byrne BJ, and Kessler PD. Human mesenchymal stem cells differentiate to a cardio-myocyte phenotype in the adult murine heart. Circulation 1: 93-98, 2002.
18. Urbanek K, Rota M, Cascapera S, Bearzi C, Nascimbene A, De Angelis A, Hosoda T, Chimenti S, Baker M, Limana F, Nurzynska D, Torella D, Rotatori F, Rastaldo R, Musso E, Quaini F, Leri A, Kajstura J, and Anversa P. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 7: 663-673, 2005.
19. van der Velden JL, Schols AM, Willems J, Kelders MC, and Langen RC. Glycogen synthase kinase 3 suppresses myo-genic differentiation through negative regulation of NFATc3. J Biol Chem 283: 358-366, 2008.
20. van der Velden JL, Langen RC, Kelders MC, Wouters EF, Janssen-Heininger YM, and Schols AM. Inhibition of gly-cogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation. Am J Physiol Cell Physiol 290: C453-462, 2006.
21. Wang Y, Kudo M, Xu M, Ayub A, and Ashraf M. Mito-chondrial K (ATP) channel as an end effector of cardiopro-tection during late preconditioning: Triggering role of nitric oxide. J Mol Cell Cardiol 11: 2037-2046, 2001.
22. Wang Y, Takashi E, Xu M, Ayub A, and Ashraf M. Down-regulation of protein kinase C inhibits activation of mito-chondrial K(ATP) channels by diazoxide. Circulation 104: 85-90, 2001.
23. Wang ZJ, Zhang FM, Wang LS, Yao YW, Zhao Q, and Gao X. Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress-induced apoptosis and enhance proliferation of MSCs via Toll-like receptor(TLR)-4 and PI3K=Akt. Cell Biol Int 33: 665-674, 2009.
24. Werner SL, Barken D, and Hoffmann, A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309: 1857-1861, 2005.